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Abstract 
 
Burkitt’s lymphoma is a subgroup of Non-Hodgkin’s lymphoma of high grade which is aggressive and composed of 
diffuse, undifferentiated malignant cells of lymphoid origin which are small and non cleaved. Clinical course is 
aggressive and rapid, commonly occurs in children and young adults with frequent involvement of Bone Marrow 
and CNS. It is considered as a medical emergency requiring immediate diagnostic and therapeutic intervention. We 
report a case of Burkitt’s lymphoma of medial part of clavicle extending into overlying pectoralis muscles, 
intercostal spaces, superior mediastinum, supraclavicular region. As per the literature available this is the first case 
of Burkitt’s lymphoma presenting primarily in medial part of clavicle. 
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Introduction 
 
 
Dennis Burkitt first described Burkitt’s lymphoma in 
1956 in equatorial Africa. It is the fastest growing 
cancers in human, growth fraction close to 100%. 
Burkitt’s lymphoma and Burkitt like lymphoma are 
highly invasive B-cell Non Hodgkin’s lymphoma with 
a aggressive and rapid progression of the disease and 
high death rate. For the past few years, the prognosis of 
the children with Burkitt’s lymphoma or BLL has 
improved, and 2 year disease free survival rate in 
advanced stage has attained 75-89 % [2].  
In the present case, Burkitt lymphoma of medial part of 
right clavicle is being presented. Primary lymphoma of 
bone is an extremely rare form of extranodal 
lymphoma, originally described in 1928 by Oberling, 
which is limited to the bone or bone marrow without 
any systemic involvement [3]. It represents around 7 % 
of all primary malignant bone tumors and less than 1 % 
of malignant lymphomas. It usually emerges from the 
medulla, presents as a localized, single lesion and can 
involve any part of the skeletal body [3].  
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The present case is of Primary Burkitt lymphoma in 17 
year old Indian female arising in medial part of right 
clavicle. As per the literature available and searched on 
internet, this is the first case of Primary Burkitt 
lymphoma of clavicle. 
 
Case report 
 
A 17 year Indian female presented with swelling in 
right supraclaviclar region (Fig 1). She was subjected 
to Fine needle aspiration. Giemsa stained cytosmears 
revealed large to medium sized round cells with open 
nuclear chromatin, irregular nuclear contours, 
conspicuous nucleoli, vacuolations in cytoplasm. 
Mitotic figures were seen. Cytological diagnosis of 
Burkitt’s lymphoma was given (Fig 2). She was then 
sent for CT scan which showed heterogeneously 
enhancing large soft tissue density mass lesion in right 
medial clavicular region with poor fat planes involving 
medial clavicle, infiltrating into overlying pectoralis 
muscles and with obliteration of subcutaneous spaces 
and minimal cutaneous edema (Fig 3).  
Lesion infiltrating into intercostal spaces, superior 
mediastinum, abutting SVC without significant luminal 
narrowing. Lesion show area of necrosis and internal 
vascularity.  
Multiple variable sized axillary, supraclavicular, 
superior mediastinum, pre, paratracheal, subcarinal and 
AP window lymphnodes were seen, largest measuring 
12 mm in size.  H&E sections of the histopathological 
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tissue showed large round cells with irregular nuclear 
contours,open nuclear chromatin , conspicuous 
nucleoli, vacuolated cytoplasm. Mitotic figures and 
tingible body macrophages giving starry sky 
appearance were seen (Fig 4). S. LDH level was raised. 
All other laboratory investigations were within normal 
range. Immunohistochemistry was done for 
confirmation . It was positive for CD20, CD10. Bcl-
6.Ki-67 > 80 %.Negative for CD3, CD5, CD34. Bone 
marrow aspiration was done for staging which also 
revealed singly scattered cells suggestive infiltration of 
similar lymphoma cells (Fig 5). Thus diagnosis of 
Primary Burkitt’s lymphoma of medial part of right 
clavicle was established.  
 
 
Fig 1: Clinical photograph of swelling in right 
supraclavicular region                                           
Fig 2:Cytosmears,40X,show round cells with high 
N:C ratio, vacuolated cytoplasm     
 
 
 
Fig 3.CT scan showing lesion arising   from medial 
part of right clavicle                                      
Fig4: H&Esection showing starry sky appearance. 
 
 
Fig 5: Bone Marrow ,Giemsa stain,40 X  
          showing presence of lymphoma cells 
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Discussion 
 
Primary bone lymphoma is characterized as a 
lymphoma of the bone or bone marrow without proof 
of any simultaneous systemic involvement[3]. As per 
Coley’s criteria, 1950, Peripheral blood smear is 
diagnosed by lymphoma in an osseous site with no 
evidence of disease elsewhere for atleast 6 months after 
diagnosis. Presence of regional lymph node without 
histological examination, does not exclude diagnosis of 
PBL [4]. Ostrowski et al in 1987, reclassified bone 
lymphoma into 4 subgroups: Group 1- solitary primary 
bone lymphoma, Group 2- more than one bone is 
affected by no nodal or visceral disease, Group 3- 
distant nodal disease, Group 4- Visceral disease.  
According to WHO classification of tumors of soft 
tissue and bone, 2002, the criteria for a diagnosis of 
PBL are (1)- a single skeletal tumor with or without 
regional lymph node involvement (2)- multiple bone 
lesions without visceral or lymph node involvement 
[3,5].Burkitt’s lymphoma is highly aggressive B-cell 
NHL, characterized by the translocation and 
deregulation of the c-myc gene on chromosome 8[6].  
Common sites of Burkitt lymphoma are jaw, facial 
bones, distal ileum, caecum, ovaries, kidney, breast.  
Two variants of Burkitt lymphoma are sporadic and 
endemic. Separate staging system for BL has been 
developed by Ziegler (1981), Levine et al (1982), 
classified the cases of American BL as follows [7].  
Stage I- single tumor mass(extra abdominal 1A or 
abdominal 2A) 
Stage II- two separate tumor masses on the same side 
of the diaphragm. Stage III- Involvement of more than 
2 separate masses or disease on both sides of the 
diaphragm.Stage IV- pleural effusion, ascites or 
involvement of the lymph nodes (malignant cells in the 
CSF) or bone marrow. There is no racial predilection, 
males are affected 2-3 times more than females. 
Primary Burkitt’s lymphoma of bone is uncommon. 
Primary BL of medial part of clavicle is not been 
reported as per the literature available. BL is one of the 
most rapidly proliferating neoplasm with doubling time 
of as short as 25 hours [8]. Cytologically and 
histologically Burkitt’s cells are homogenous in size 
and shape, with round to oval nuclei and slightly coarse 
chromatin with multiple nucleoli and intensely 
basophilic vacuolated cytoplasm containing neutral fat. 
The hallmark of BL is the presence of starry sky 
appearance due to presence of scattered macrophages 
phagocytizing cell debris and apoptotic cells. 
Immunohistochemistry is positive for Ki-67, CD-19, 
CD-20, CD-22, CD-79a which is useful for diagnosis. 
Bone marrow and CNS involvement are reported in 30-
38 % and 13-17 % of adults with Burkitt lymphoma, 
respy [9]. With aggressive chemotherapy, complete 
remission rates are 75-90 % and overall long-term 
survival rate is 50-70 % in adults [8]. Massive acute 
destruction of the tumor cells during initial 
chemotherapy due to rapid growth rate may result in 
tumor lysis syndrome. In the present case, patient was 
given chemotherapy, taking care of tumor lysis 
syndrome. After 6 months of chemotherapy, patient is 
well with no residual disease.  
 
Conclusion 
 
Fine needle aspiration cytology is the best mode of 
investigation for early, accurate, minimally invasive for 
diagnosis of Burkitt’ lymphoma. Histopahtology and 
IHC are further diagnostic tools for confirmation of the 
diagnosis. Early diagnosis can be life saving for Burkitt 
lymphoma. As per the available literature, this is the 
FIRST case of Primary Burkitt’s lymphoma involving 
the medial part of right clavicle.  
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